Recent data do not provide evidence that resveratrol causes ‘mainly negative’ or ‘adverse’ effects on exercise training in humans

A healthier approach to clinical trials evaluating resveratrol for primary prevention of age-related diseases in healthy populations

(2016) James M. Smoliga et al.   Aging-US

Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men

(2013) Lasse Gliemann et al.   JOURNAL OF PHYSIOLOGY-LONDON

Resveratrol Supplementation Does Not Improve Metabolic Function in Nonobese Women with Normal Glucose Tolerance

(2012) Jun Yoshino et al.   Cell Metabolism

Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells

(2012) P. Skrobuk et al.   DIABETOLOGIA

Type I: families, planning and errors

(2012) Gordon B. Drummond et al.   JOURNAL OF PHYSIOLOGY-LONDON

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

Erroneous analyses of interactions in neuroscience: a problem of significance

(2011) Sander Nieuwenhuis et al.   NATURE NEUROSCIENCE

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

(2010) V. A. Brown et al.   CANCER RESEARCH